FDA rules that a diagnostic test is needed prior to approval of anti-leukaemia drug, Omapro. [ + ]

Life science sector lagging behind in adoption of IT, representing a $17 billion opportunity for IT providers. [ + ]

An international research team has identified new gene variants associated with gluten intolerance. [ + ]

The 'doublesex' gene shapes brain, body and behaviour, at least when it comes to fruit flies. [ + ]

Many illnesses can be reliably diagnosed through laboratory tests, but these in vitro analyses often use up valuable time. A system developed by Fraunhofer research scientists, which can carry out complex analyses on the spot, will soon be ready for the market.

Cochlar, CSL, ResMed, Living Cell Technology, Mesoblast [ + ]

Study shows transcription factors play a larger roll than expected in explaining individual differences. [ + ]

Vaccination by mosquito could become a new method of protecting people from diseases. [ + ]

A Thomson Reuters study reveals that Australia's share of world research publication is increasing and that collaboration with China is the fastest growing area.

Phase III trial shows breast cancer drug, Abraxane, effective against lung cancer. [ + ]

Australian Life Scientist Biotechnology Directory launches providing portal to the Australian biotechnology community. [ + ]

Following success from last year, AusBiotech will hold another investment summit in October. [ + ]

A new approach to combating antibiotic resistance draws on lessons learned from targeted therapies for cancer. [ + ]

ResMed and rival challenged by disgruntled distributor over access to products. [ + ]

Living Cell Technology, Ansell, ChemGenex, Biota Holdings, Sonic Healthcare, ResMed, CSL [ + ]